PT Bukalapak.com Tbk. (IDX:BUKA)
Indonesia · Delayed Price · Currency is IDR 175.00
+3.00 (1.74%)
Aug 8, 2025, 3:49 PM WIB
Theseus Pharmaceuticals Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
| 5,134,708 | 4,460,266 | 4,438,269 | 3,618,366 | 1,869,122 | 1,351,664 | Upgrade | |
Revenue Growth (YoY) | 9.96% | 0.50% | 22.66% | 93.59% | 38.28% | 25.55% | Upgrade |
Cost of Revenue | 4,625,489 | 3,743,583 | 3,387,569 | 2,559,910 | 441,425 | 123,260 | Upgrade |
Gross Profit | 509,220 | 716,683 | 1,050,700 | 1,058,456 | 1,427,697 | 1,228,404 | Upgrade |
Selling, General & Admin | 1,083,619 | 1,352,785 | 1,867,063 | 3,572,411 | 3,091,689 | 3,017,198 | Upgrade |
Other Operating Expenses | 67,696 | 42,390 | -10,231 | -15,446 | 10,468 | 25,246 | Upgrade |
Operating Expenses | 1,151,316 | 1,395,175 | 1,856,833 | 3,556,965 | 3,102,157 | 3,042,444 | Upgrade |
Operating Income | -642,096 | -678,493 | -806,133 | -2,498,509 | -1,674,460 | -1,814,040 | Upgrade |
Interest Expense | -3,636 | -2,292 | -3,366 | -5,704 | -18,064 | -8,341 | Upgrade |
Interest & Investment Income | 512,096 | 1,042,293 | 825,282 | 541,044 | 226,612 | 14,078 | Upgrade |
Earnings From Equity Investments | -53,089 | -49,475 | -30,877 | -23,349 | - | - | Upgrade |
Currency Exchange Gain (Loss) | -51,521 | 282,769 | -60,837 | 359,170 | -116.36 | 31,666 | Upgrade |
Other Non Operating Income (Expenses) | 448,142 | -2,379 | -2,131 | -1,374 | -241.89 | -206.35 | Upgrade |
EBT Excluding Unusual Items | 209,895 | 592,424 | -78,062 | -1,628,723 | -1,466,270 | -1,776,843 | Upgrade |
Merger & Restructuring Charges | -426,288 | -426,288 | - | - | - | - | Upgrade |
Impairment of Goodwill | -67,914 | -75,037 | -30,254 | -30,531 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -20,574 | -1,611,407 | -1,229,920 | 3,935,085 | -21,745 | -40,070 | Upgrade |
Gain (Loss) on Sale of Assets | -1,384 | -2,098 | 431.88 | -5,622 | -12,966 | -15,230 | Upgrade |
Asset Writedown | -8,073 | -7,219 | -5,016 | - | - | - | Upgrade |
Pretax Income | -314,339 | -1,529,626 | -1,342,820 | 2,270,209 | -1,500,980 | -1,832,143 | Upgrade |
Income Tax Expense | 19,210 | 18,838 | 34,724 | 292,615 | 174,764 | -483,101 | Upgrade |
Earnings From Continuing Operations | -333,548 | -1,548,463 | -1,377,544 | 1,977,594 | -1,675,744 | -1,349,042 | Upgrade |
Minority Interest in Earnings | 1,443 | - | - | 6,036 | 2,784 | 0.57 | Upgrade |
Net Income | -332,105 | -1,548,463 | -1,377,544 | 1,983,630 | -1,672,959 | -1,349,042 | Upgrade |
Net Income to Common | -332,105 | -1,548,463 | -1,377,544 | 1,983,630 | -1,672,959 | -1,349,042 | Upgrade |
Shares Outstanding (Basic) | 103,173 | 103,122 | 103,100 | 103,063 | 103,062 | 8 | Upgrade |
Shares Outstanding (Diluted) | 103,173 | 103,122 | 103,100 | 104,219 | 103,062 | 8 | Upgrade |
Shares Change (YoY) | 0.06% | 0.02% | -1.07% | 1.12% | 1309944.91% | 2.95% | Upgrade |
EPS (Basic) | -3.22 | -15.02 | -13.36 | 19.25 | -16.23 | -171479.76 | Upgrade |
EPS (Diluted) | -3.22 | -15.02 | -13.36 | 19.03 | -16.23 | -171480.00 | Upgrade |
Free Cash Flow | 220,652 | 268,739 | 32,040 | -644,144 | -1,411,361 | -1,169,159 | Upgrade |
Free Cash Flow Per Share | 2.14 | 2.61 | 0.31 | -6.18 | -13.69 | -148614.49 | Upgrade |
Gross Margin | 9.92% | 16.07% | 23.67% | 29.25% | 76.38% | 90.88% | Upgrade |
Operating Margin | -12.50% | -15.21% | -18.16% | -69.05% | -89.59% | -134.21% | Upgrade |
Profit Margin | -6.47% | -34.72% | -31.04% | 54.82% | -89.50% | -99.81% | Upgrade |
Free Cash Flow Margin | 4.30% | 6.02% | 0.72% | -17.80% | -75.51% | -86.50% | Upgrade |
EBITDA | -626,207 | -657,735 | -783,589 | -2,440,599 | -1,539,054 | -1,647,818 | Upgrade |
EBITDA Margin | -12.20% | -14.75% | -17.66% | -67.45% | -82.34% | -121.91% | Upgrade |
D&A For EBITDA | 15,889 | 20,757 | 22,543 | 57,910 | 135,406 | 166,221 | Upgrade |
EBIT | -642,096 | -678,493 | -806,133 | -2,498,509 | -1,674,460 | -1,814,040 | Upgrade |
EBIT Margin | -12.50% | -15.21% | -18.16% | -69.05% | -89.59% | -134.21% | Upgrade |
Effective Tax Rate | - | - | - | 12.89% | - | - | Upgrade |
Advertising Expenses | - | 77,714 | 67,979 | 201,079 | 220,737 | 216,796 | Upgrade |
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.